iHuman acquires All Knowledge and Perfect Lingo

iHuman Inc., a technology-based intellectual development company, has announced its acquisition of businesses and assets linked to two AI-driven learning applications, All Knowledge and Perfect Lingo. The acquisition, valued at ¥94 million (approximately $1 million USD), aims to bolster iHuman's offerings in AI-powered education. The transaction is structured with potential adjustments and includes contingent earn-out payments that could bring the total deal value to approximately ¥135 million.

The acquisition will see iHuman enhancing its portfolio with All Knowledge, an application concentrating on AI literacy and humanities. This app facilitates user interaction with historical, cultural, and philosophical content through AI tools like spatio-temporal views and relationship graphs. It also provides systematic learning products targeting literature and history enthusiasts. Perfect Lingo complements this by focusing on English language acquisition, offering users AI-enhanced tools to build vocabulary, improve pronunciation, and develop language skills through practical engagement and video learning. The transaction includes appointing Teng Li as Co-CEO and Congyu Lin as Chief Strategy Officer, both from the newly acquired entities.

These acquisitions are part of iHuman's strategic efforts to expand its product offerings in the educational technology sector by leveraging AI capabilities. The company, already known for its tech-based educational products, sees these apps as a means to further penetrate the AI education market with new, robust content offerings. Executives assert that the combined strengths of these platforms will enhance the company's competitive position and market reach, aligning with its growth and diversification strategy.

The deal was classified as a related party transaction under common control, approved by both iHuman's board and audit committee, following an independent valuation by a Big Four accounting firm. This highlights a collaborative focus within the company's overarching control framework, contrasting with broader market dynamics where iHuman's share price has remained stable despite volatility in the sector. Competitors like SPG have experienced declines, underscoring the stock-specific nature of iHuman's moves.

Pending satisfaction of closing conditions, the targeted acquisitions will face scrutiny concerning their integration and performance against contingent earn-out targets. Market observers and investors will be keenly watching how iHuman navigates these developments, particularly in relation to its financial health and the effectiveness of its newly appointed executives in steering this expansion.